Vanderbilt rejected by high court on Cialis patents

The U.S. Supreme Court refused to revive a bid by Vanderbilt University to have three of its scientists named as co-inventors on patents covering Eli Lilly and Co.'s Cialis impotence drug.

The justices on Monday left intact a ruling throwing out a lawsuit pressed by the Nashville, Tenn., university against Lilly’s Icos subsidiary. A federal appeals court, upholding a trial judge, concluded that the scientists didn’t play a role in creating the drug. Vanderbilt then asked the nation’s highest court to intervene.

Cialis in 2010 had third-quarter sales of $153.5 million in the United States and $406.5 million worldwide. Indianapolis-based Lilly acquired Icos and gained full control over Cialis in 2007.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our updated comment policy that will govern how comments are moderated.